#VisualAbstract: Addition of argatroban to intravenous alteplase did not improve neurologic outcomes in patients with acute ischemic stroke
Click here to read this study in NEJM
Click here to read this study in NEJM
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
1. Fewer patients in the thrombectomy group achieved an MRS score of 0-2 at 90 days compared to thrombectomy with ...
1. IV tenecteplase was non-inferior to IV alteplase for treatment of acute ischemic stroke regarding the primary outcome of a ...
1. Fewer patients in the direct thrombectomy achieved functional independence at 90 days compared to the bridging therapy group. 2. ...
1. Fewer patients in the thrombectomy group achieved an MRS score of 0-2 at 90 days compared to thrombectomy with ...
1. Patients with large cerebral infarctions receiving endovascular therapy with medical care had better functional outcomes than patients receiving medical ...
1. Patients in the thrombectomy group reported a greater independence in daily living compared to those receiving best medical therapy ...
1. Patients receiving intravenous alteplase before endovascular treatment had similar disability outcomes of symptomatic intracerebral hemorrhage post-stroke compared to patients ...
1. In patients with spontaneous intracerebral hemorrhage and intraventricular hemorrhage, intraventricular alteplase use was associated with a small reduction in ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.